Archives

by in
Entry Author Date Location
Healthcare Is Transforming Regardless of What Happens to the ACA 04/15/15 Seattle
A New Day for Digital DNA 04/14/15 Boston
Tax Time Alert: Key Things to Know About Founders Preferred Stock 04/10/15 Boston
Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place 04/06/15 Seattle
Peter Thiel Brings Libertarian Standup Routine to Harvard 03/30/15 Boston
Fastest Turtle: Healthcare Investing and the U.S. Economy 03/23/15 Boston
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
For Life Science Industry, Social Media Takes on New Significance 02/19/15 Raleigh Durham
Biotech M&A by Slow Simmer: An Inside Look at the Build to Buy Deal 02/18/15 New York
Why Boston Biotech Should Look to London 02/09/15 Boston
Resistance Is Futile: Why That’s A Good Thing In Biomedicine 02/09/15 Seattle
Milestones of Innovation 2: Gregor Mendel on Heredity, 1865 02/08/15 National
Innovation Outlook for 2015: Tackling Big Data Variety 01/26/15 Boston
Crowdfunding is Banging on Biotech’s Door. Will We Let It In? 01/21/15 Boston
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
In Search of a Better Approach to Breast Cancer Screening 01/14/15 San Francisco
Even When Money is Easy, Rules of Biotech Finance Still Apply 01/07/15 San Diego
Implications of the Oil Price Collapse 01/05/15 Boston
Hepatitis C Commercial Game Theory 01/01/15 National
10 Bits of Advice for Students Interested in Drug Development 12/28/14 Wisconsin
Kicking the Cyber Attack Can Down the Road 12/27/14 Boston
What’s the Most Important Issue That Didn’t Get Addressed in 2014? 12/24/14 Boston
Rethinking Venture Philanthropy After the Kalydeco Windfall 12/22/14 Boston
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
Breaking Bottlenecks, Opening the Floodgates to Genomic Data 11/18/14 National
Lowering the Cost of Failure in Biopharmaceuticals 11/11/14 Boston
Beg, Borrow, or Steal: Accessing Unaffordable Science Journals 11/10/14 National
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
Page 1 of 11 next page »